Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
In order to understand how pharmacokinetics and immunological inactivation affect the
therapeutic efficacy of Asparaginase (ASP), it is of help and advised in the frame of
clinical font-line protocols to monitor the enzymatic activity by measuring the serum ASP
levels in the days following the administration of the drug.